Carlotta Scarpa, Vincenzo Vindigni, and Franco Bassetto, “The TLC-NOSF (Technology Lipido-Colloid Plus Nano-Oligo Saccharide Factor) protease inhibitor for the treatment of ulceration in rheumatic disease”, Ann Ital Chir, vol. 9, no. September, pp. 1–3, Oct. 2020.